Cancer Immunotherapy Principles and Practice
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 66)

H-INDEX

(FIVE YEARS 0)

Published By Springer Publishing Company

9780826137425, 9780826137432

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Immunotherapy for Lung Cancer and Malignant Pleural Mesothelioma

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0057 ◽

2021 ◽

Author(s):

Paola Ghanem ◽

Julie R Brahmer

Keyword(s):

Lung Cancer ◽

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma

Download Full-text

A Regulatory Perspective on Cell Therapy for Cancer: Chemistry, Manufacturing and Control, Preclinical, and Clinical Considerations

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0065 ◽

2021 ◽

Author(s):

Ke Liu ◽

Jaikumar Duraiswamy ◽

Thomas Finn ◽

Brian Niland ◽

Allen Wensky ◽

...

Keyword(s):

Cell Therapy ◽

Regulatory Perspective ◽

Clinical Considerations ◽

And Control

Download Full-text

Gene Therapy-Based Immunotherapy Products for Human Clinical Trials: Chemistry, Manufacturing and Control, Preclinical, and Clinical Considerations: An FDA Perspective

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0066 ◽

2021 ◽

Author(s):

Ramjay S. Vatsan ◽

Y Nguyen ◽

Allen Wensky ◽

Chaohong Fan ◽

Ke Liu ◽

...

Keyword(s):

Gene Therapy ◽

Clinical Trials ◽

Clinical Considerations ◽

And Control

Download Full-text

Clinical Measures: Tumor Response Assessments, Pseudoprogression, and Immunometabolism

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0048 ◽

2021 ◽

Author(s):

Louis F Chai ◽

Steven C Katz

Keyword(s):

Tumor Response ◽

Clinical Measures

Download Full-text

Cancer Biomarkers: Tumor-Infiltrating T Cells, Programmed Death-Ligand 1, and Tumor Mutation Burden

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0018 ◽

2021 ◽

Author(s):

Colt Egelston ◽

Weihua Guo ◽

Peter P. Lee

Keyword(s):

T Cells ◽

Cancer Biomarkers ◽

Tumor Mutation Burden ◽

Programmed Death Ligand 1 ◽

Mutation Burden ◽

Programmed Death

Download Full-text

Circulating Mediators of Tumor-Induced Immune Suppression

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0041 ◽

2021 ◽

Author(s):

Theresa L. Whiteside

Keyword(s):

Immune Suppression

Download Full-text

Tumor Microenvironment Metabolism as a Primordial Checkpoint in Antitumor T Cell Immunity

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0046 ◽

2021 ◽

Author(s):

Greg M. Delgoffe

Keyword(s):

T Cell ◽

Tumor Microenvironment ◽

T Cell Immunity ◽

Cell Immunity

Download Full-text

Immunotherapy in Melanoma

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0050 ◽

2021 ◽

Author(s):

Antonio Maria Grimaldi ◽

Igor Puzanov ◽

Paolo A. Ascierto

Download Full-text

Functional Status of T Cells: Stemness Versus Terminal Differentiation

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0010 ◽

2021 ◽

Author(s):

Alessandra Cesano ◽

Alper Kearney ◽

Francesco M Marincola

Keyword(s):

T Cells ◽

Functional Status ◽

Terminal Differentiation

Download Full-text

Natural Killer Cell Effector Mechanisms Against Solid Tumors and Leukemias and Their Exploitation in Immunotherapy

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0012 ◽

2021 ◽

Author(s):

Andrea De Maria ◽

Lorenzo Moretta ◽

Gabriella Pietra ◽

Massimo Vitale

Keyword(s):

Natural Killer Cell ◽

Natural Killer ◽

Solid Tumors ◽

Killer Cell ◽

Cell Effector ◽

Effector Mechanisms

Download Full-text

Cancer Immunotherapy Principles and PracticeLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer Publishing Company

Immunotherapy for Lung Cancer and Malignant Pleural Mesothelioma

A Regulatory Perspective on Cell Therapy for Cancer: Chemistry, Manufacturing and Control, Preclinical, and Clinical Considerations

Gene Therapy-Based Immunotherapy Products for Human Clinical Trials: Chemistry, Manufacturing and Control, Preclinical, and Clinical Considerations: An FDA Perspective

Clinical Measures: Tumor Response Assessments, Pseudoprogression, and Immunometabolism

Cancer Biomarkers: Tumor-Infiltrating T Cells, Programmed Death-Ligand 1, and Tumor Mutation Burden

Circulating Mediators of Tumor-Induced Immune Suppression

Tumor Microenvironment Metabolism as a Primordial Checkpoint in Antitumor T Cell Immunity

Immunotherapy in Melanoma

Functional Status of T Cells: Stemness Versus Terminal Differentiation

Natural Killer Cell Effector Mechanisms Against Solid Tumors and Leukemias and Their Exploitation in Immunotherapy

Cancer Immunotherapy Principles and Practice
Latest Publications